This article refers to:
Article title: Tumour-targeting bacteria as immune stimulants – the future of cancer immunotherapy?
Authors: Alexandra M. Mowday, Jella M. van de Laak, Zhe Fu, Kimiora L. Henare, Ludwig Dubois, Philippe Lambin, Jan Theys and Adam V. Patterson
Journal: Critical Reviews in Microbiology
DOI: https://doi.org/10.1080/1040841X.2024.2311653
When this article was first published online, the disclosure statement was incorrect. This has been corrected as below:
Disclosures from the last 36 months within the submitted work: grants/sponsored research agreements with LivingMed Biotech and Bactam. PL has minority shares in LivingMed Biotech and Bactam. He confirms that none of the above entities were involved in the preparation of this paper.